Aquestive Therapeutics (AQST) Gross Margin (2017 - 2026)
Aquestive Therapeutics (AQST) posted quarterly Gross Margin of 93.26% for Q1 2026, up 3515.0% year-over-year from 2.58% in Q1 2025, and up 20.84% quarter-over-quarter from 77.18% in Q4 2025.
Aquestive Therapeutics (AQST) Gross Margin (2017 - 2026) Analysis & Trends
Aquestive Therapeutics' Gross Margin history runs 10 years deep, the most recent figure standing at 93.26% for Q1 2026.
- In Q1 2026, Gross Margin rose 3515.0% year-over-year to 93.26%; the TTM figure through Mar 2026 stood at 147.15% (up 5001.0% YoY), while the FY2025 annual figure was 511.62%, down 60214.0% from the prior year.
- Gross Margin for Q1 2026 stood at 93.26%, up from 77.18% in the prior quarter.
- The five-year high for Gross Margin was 166.51% in Q4 2024, with the low at 34.48% in Q2 2022.
- The 5-year median for Gross Margin is 77.18% (2025), against an average of 79.11%.
- The sharpest annual moves came in 2022 and 2025: Gross Margin surged 15778 bps in 2022, then tumbled 8934 bps in 2025.
- Aquestive Therapeutics' Gross Margin stood at 50.34% in 2022, then gained by 16 bps to 58.49% in 2023, then surged by 185 bps to 166.51% in 2024, then slumped by 54 bps to 77.18% in 2025, then grew by 21 bps to 93.26% in 2026.
- Business Quant data shows AQST's Gross Margin at 93.26% in Q1 2026, 77.18% in Q4 2025, and 88.81% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 51.98% |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 42.63% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 66.66% |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 87.30% |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 38.77% |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 97.58% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 58.33% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Aquestive Therapeutics | 552.47 Mn | 552.47 Mn | 9.80 Mn | 70.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 70.93% |
| Mar 31, 2026 | 93.26% |
| Dec 31, 2025 | 77.18% |
| Sep 30, 2025 | 88.81% |
| Jun 30, 2025 | 85.66% |
| Mar 31, 2025 | 58.12% |
| Dec 31, 2024 | 166.51% |
| Sep 30, 2024 | 67.24% |
| Jun 30, 2024 | 93.24% |
| Mar 31, 2024 | 88.73% |
| Dec 31, 2023 | 58.49% |
| Sep 30, 2023 | 100.00% |
| Jun 30, 2023 | 100.00% |
| Mar 31, 2023 | 57.45% |
| Dec 31, 2022 | 50.34% |
| Sep 30, 2022 | 59.65% |
| Jun 30, 2022 | 34.48% |
| Mar 31, 2022 | 65.66% |
| Dec 31, 2021 | 69.62% |
| Sep 30, 2021 | 66.88% |